Edgewise Therapeutics, Inc. (EWTX)
27.39
+0.79
(+2.97%)
USD |
NASDAQ |
Jan 16, 16:00
27.40
+0.02
(+0.05%)
After-Hours: 20:00
Edgewise Therapeutics EPS Diluted (Quarterly): -0.3855 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Dynavax Technologies Corp. | 0.2063 |
| Omeros Corp. | -0.4666 |
| Gilead Sciences, Inc. | 2.434 |
| Agios Pharmaceuticals, Inc. | -1.779 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -40.67M |
| Total Expenses (Quarterly) | 40.67M |
| Enterprise Value | 2.341B |
| Earnings Yield | -5.76% |
| Normalized Earnings Yield | -5.758 |